AbbVie
ABBV
#26
Rank
โ‚ฌ335.52 B
Marketcap
189,84ย โ‚ฌ
Share price
-1.05%
Change (1 day)
16.96%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ116.29 Billion

According to AbbVie's latest financial reports the company's total liabilities are โ‚ฌ116.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ126.65 B12.63%
2023-12-31โ‚ฌ112.45 B-0.73%
2022-12-31โ‚ฌ113.28 B-2.13%
2021-12-31โ‚ฌ115.75 B3.57%
2020-12-31โ‚ฌ111.76 B28.69%
2019-12-31โ‚ฌ86.84 B46.54%
2018-12-31โ‚ฌ59.26 B8.25%
2017-12-31โ‚ฌ54.74 B-6.31%
2016-12-31โ‚ฌ58.43 B30.11%
2015-12-31โ‚ฌ44.91 B111.94%
2014-12-31โ‚ฌ21.18 B18.45%
2013-12-31โ‚ฌ17.88 B0.08%
2012-12-31โ‚ฌ17.87 B205.89%
2011-12-31โ‚ฌ5.84 B43.1%
2010-12-31โ‚ฌ4.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ98.52 B-15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ66.70 B-42.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ77.60 B-33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ68.60 B-41.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ31.58 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.37 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ52.21 B-55.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚ฌ58.34 B-49.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ1.07 B-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA